61 pending office actions
| App # | Title | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|
| 19067038 | METHODS AND SYSTEMS FOR PHYSICAL EXPANSION AND IMAGING OF BIOLOGICAL SAMPLES | LYONS, MARY M | 1645 | Non-Final OA | Feb 28, 2025 |
| 18790607 | Protein Capture Membrane and Method of Use Thereof | BRAZIN, JACQUELINE | 1798 | Non-Final OA | Jul 31, 2024 |
| 18674209 | POLY(AMINE-CO-ESTER) POLYMERS AND POLYPLEXES WITH MODIFIED END GROUPS AND METHODS OF USE THEREOF | COHEN, MICHAEL P | 1612 | Non-Final OA | May 24, 2024 |
| 18660594 | MACHINE LEARNING SYSTEM AND METHODS FOR INCREASING APPOINTMENT COMPLIANCE | GILLIGAN, CHRISTOPHER L | 3683 | Final Rejection | May 10, 2024 |
| 18653162 | Bioprinting of Collagenous Bioinks | SWANSON, ANDREW L | 1745 | Non-Final OA | May 02, 2024 |
| 18616372 | ENDOBRONCHIAL BLOCKER SYSTEM AND APPARATUS | HOAG, MITCHELL BRAIN | 3771 | Final Rejection | Mar 26, 2024 |
| 18614093 | Polymeric Composites Having Oriented Nanopores and Methods of Making the Same | DAGENAIS, KRISTEN A | 1717 | Final Rejection | Mar 22, 2024 |
| 18569379 | COMPOUNDS AND METHODS FOR TREATING OR PREVENTING AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD), AUTOSOMAL DOMINANT POLYCYSTIC LIVER DISEASE (ADPLD) AND/OR AUTOSOMAL RECESSIVE POLYCYSTIC KIDNEY DISEASE (ARPKD) | LEWIS, PATRICK T | 1691 | Non-Final OA | Dec 12, 2023 |
| 18516195 | PEDIATRIC FORMULATION OF TYROSINE KINASE INHIBITORS | GOTFREDSON, GAREN | 1619 | Non-Final OA | Nov 21, 2023 |
| 18557008 | ON-CHIP SPECTROMETER WITH TUNABLE PHOTODETECTION LAYER | LIU, BENJAMIN T | 2893 | Non-Final OA | Oct 24, 2023 |
| 18555112 | COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF CANCER | COUGHLIN, MATTHEW P | 1626 | Non-Final OA | Oct 12, 2023 |
| 18277505 | MULTIMODE SUPERCONDUCTING CAVITY RESONATORS | HOSSAIN, MOAZZAM | 2898 | Non-Final OA | Aug 16, 2023 |
| 18446296 | Bi-functional Molecules To Degrade Circulating Proteins | SCHMITT, MICHAEL J | 1629 | Non-Final OA | Aug 08, 2023 |
| 18357810 | MULTIFUNCTIONAL pO2/pH-SENSITIVE THERANOSTIC LIPOSOME NANOCARRIERS AND METHODS OF USING SAME | ROSENTHAL, ANDREW S | 1613 | Non-Final OA | Jul 24, 2023 |
| 18349851 | FLUORESCENT COMPOUND COMPRISING A FLUOROPHORE CONJUGATED TO A pH-TRIGGERED POLYPEPTIDE | DICKINSON, PAUL W | 1618 | Non-Final OA | Jul 10, 2023 |
| 18260744 | Non-Covalent Inhibitors of the Main Protease of SARS-CoV-2 and Methods of Use | FETTEROLF, BRANDON J | 1626 | Non-Final OA | Jul 07, 2023 |
| 18266917 | USE OF MGLUR5 ANTAGONISTS FOR TREATING GAMBLING DISORDER | ROZOF, TIMOTHY R | 1625 | Non-Final OA | Jun 13, 2023 |
| 18330357 | Blockade of miR466l-3p binding to IL-17A mRNA with site-specific target site blocker prevents neuro-inflammatory-mediated disease | CHONG, KIMBERLY | 1636 | Final Rejection | Jun 06, 2023 |
| 18314688 | IMMUNOTHERAPY OF SKIN CANCER USING MPLA-LOADED HPG NANOPARTICLES | RONEY, CELESTE A | 1612 | Final Rejection | May 09, 2023 |
| 18308357 | METHOD OF TREATING, AMELIORATING AND/OR PREVENTING DEPRESSION | ROZOF, TIMOTHY R | 1625 | Non-Final OA | Apr 27, 2023 |
| 18250530 | Macrophage Migration Inhibitory Factor Inhibitors, and Methods of Making and Using Same | HASTINGS, ALISON AZAR | 1627 | Non-Final OA | Apr 25, 2023 |
| 18133900 | DEVICE AND METHOD FOR OBTAINING IMMUNO-STIMULATORY ANTIGEN-PRESENTING CELLS | JUEDES, AMY E | 1644 | Non-Final OA | Apr 12, 2023 |
| 18299324 | Reverse Transcriptase and Methods of Use | KANE, TREVOR LOGAN | 1657 | Non-Final OA | Apr 12, 2023 |
| 18044076 | WEARABLE AIR POLLUTANT MONITORING DEVICE | RAEVIS, ROBERT R | 2855 | Final Rejection | Mar 03, 2023 |
| 18043534 | COMPOSITIONS AND METHODS FOR DELIVERY OF NUCLEIC ACIDS TO CELLS | LANDSMAN, ROBERT S | 1647 | Non-Final OA | Feb 28, 2023 |
| 18042993 | Compounds and Compositions for Disrupting Programmed Ribosomal Frameshifting | KIM, SEONG JONG | 1621 | Non-Final OA | Feb 24, 2023 |
| 18040484 | POLYMERIC COMPOSITE MEMBRANES HAVING ORIENTED NANOCHANNELS AND METHODS OF MAKING THE SAME | MCCULLOUGH, ERIC J. | 1773 | Non-Final OA | Feb 03, 2023 |
| 18005444 | COMPOSITIONS AND METHODS RELATING TO TYPHOID TOXIN SUBUNIT PLTC | DEVI, SARVAMANGALA | 1645 | Non-Final OA | Jan 13, 2023 |
| 18003125 | Compositions and Methods for Selective Detection and/or Inhibition of Bacterial Pathogens in Microbial Communities | BREEN, KIMBERLY CATHERINE | 1657 | Final Rejection | Dec 22, 2022 |
| 18002710 | PanK Modulators and Methods Using Same | VISHNYAKOVA, ELENA VLADIMIROVNA | 1691 | Non-Final OA | Dec 21, 2022 |
| 18002477 | Methods of Treating, Ameliorating, Shortening Duration, and/or Reversing Symptoms and/or Complications of a Coronavirus Infection | RZECZYCKI, PHILLIP MATTHEW | 1625 | Final Rejection | Dec 19, 2022 |
| 18000957 | COMPOSITIONS AND METHODS FOR TREATING AND/OR PREVENTING COAGULOPATHY AND/OR SEPSIS IN PATIENTS SUFFERING FROM BACTERIAL AND/OR VIRAL INFECTIONS | MOLOYE, TITILAYO | 1632 | Non-Final OA | Dec 07, 2022 |
| 17999324 | AN INTEGRATED DIELECTROPHORESIS-TRAPPING AND NANOWELL TRANSFER APPROACH TO ENABLE DOUBLE-SUB-POISSON SINGLE-CELL RNA-SEQUENCING | CHUNDURU, SURYAPRABHA | 1681 | Final Rejection | Nov 18, 2022 |
| 17995072 | METHODS FOR TREATING INFLAMMATORY AND FIBROTIC DISEASES AND DISORDERS | MI, QIUWEN | 1655 | Non-Final OA | Sep 29, 2022 |
| 17822332 | TARGETED MEASURE OF TRANSCRIPTIONAL ACTIVITY RELATED TO HORMONE RECEPTORS | JOHANNSEN, DIANA B | 1682 | Non-Final OA | Aug 25, 2022 |
| 17822245 | TREATMENT OF DISEASES INVOLVING DEFICIENCY OF ENPP1 OR ENPP3 | MOLOYE, TITILAYO | 1632 | Non-Final OA | Aug 25, 2022 |
| 17845461 | COMPOSITION AND METHODS FOR CULTURING RETINAL PROGENITOR CELLS | MOLOYE, TITILAYO | 1632 | Final Rejection | Jun 21, 2022 |
| 17782914 | COMPOSITIONS AND METHODS FOR PREVENTING RECURRENCE OF CANCER | BOECKELMAN, JACOB A | 1655 | Non-Final OA | Jun 06, 2022 |
| 17782338 | A T cell-based immunotherapy for central nervous system viral infections and tumors | ALSOMAIRY, SARAH ABDOALATIF | 1646 | Final Rejection | Jun 03, 2022 |
| 17756212 | COMPOUNDS, COMPOSITIONS, AND METHODS FOR TREATING ISCHEMIA-REPERFUSION INJURY AND/OR LUNG INJURY | SCHMITT, MICHAEL J | 1629 | Non-Final OA | May 19, 2022 |
| 17776922 | METHODS OF INDUCING OR ENHANCING FARNESOID X RECEPTOR (FXR)-MEDIATED TRANSCRIPTIONAL RESPONSE | CHANDRAKUMAR, NIZAL S | 1625 | Non-Final OA | May 13, 2022 |
| 17769642 | COMPOSITIONS AND METHODS FOR INHIBITION OF CELL-PENETRATING ANTIBODIES | PATTERSON, SARAH COOPER | 1675 | Non-Final OA | Apr 15, 2022 |
| 17768166 | TARGETED BIFUNCTIONAL DEGRADERS | GOTFREDSON, GAREN | 1619 | Non-Final OA | Apr 11, 2022 |
| 17768145 | ENGINEERED ANTIBODIES AS MOLECULAR DEGRADERS THROUGH CELLULAR RECEPTORS | HIBSHMAN, SARAH GRACE | 1693 | Non-Final OA | Apr 11, 2022 |
| 17767852 | COMPOSITIONS AND METHODS FOR UPREGULATING ISOFORMS OF DYSTROPHIN AS THERAPY FOR DUCHENNE MUSCULAR DYSTROPHY (DMD) | ALLEN, SARAH ELIZABETH | 1637 | Final Rejection | Apr 08, 2022 |
| 17764804 | DETERMINISTIC BARCODING FOR SPATIAL OMICS SEQUENCING | FLINDERS, JEREMY C | 1684 | Final Rejection | Mar 29, 2022 |
| 17654984 | ENGINEERED ANTIBODIES AS MOLECULAR DEGRADERS THROUGH CELLULAR RECEPTORS | HIBSHMAN, SARAH GRACE | 1693 | Non-Final OA | Mar 15, 2022 |
| 17641516 | NANOPARTICLES FOR SELECTIVE TISSUE OR CELLULAR UPTAKE | LAZARO, DOMINIC | 1611 | Final Rejection | Mar 09, 2022 |
| 17673034 | COMPOSITIONS AND METHODS FOR TREATING AUTOIMMUNE DISEASES AND CANCERS | FORD, VANESSA L | 1674 | Final Rejection | Feb 16, 2022 |
| 17620182 | IN-SITU AND SELECTIVE AREA ETCHING OF SURFACES OR LAYERS, AND HIGH-SPEED GROWTH OF GALLIUM NITRIDE, BY ORGANOMETALLIC CHLORINE PRECURSORS | BRATLAND JR, KENNETH A | 1714 | Final Rejection | Dec 17, 2021 |
| 17524038 | COMPOSITIONS AND METHODS FOR GRAFTS MODIFIED WITH A NON-THROMBOGENIC AND PRO-MIGRATORY CELL-DERIVED EXTRACELLULAR MATRIX | PYLA, EVELYN Y | 1633 | Non-Final OA | Nov 11, 2021 |
| 17510981 | METHOD FOR OBTAINING IMMUNO-STIMULATORY DENDRITIC CELLS | SCHUBERG, LAURA J | 1631 | Non-Final OA | Oct 26, 2021 |
| 17600984 | METHODS OF TREATMENT OF DISEASES AND DISORDERS ASSOCIATED WITH INCREASED TET LEVEL, INCREASED H19 LEVEL, INCREASED LEVEL OF TGF SIGNALING, OR ANY COMBINATION THEREOF | MCKILLOP, JOHN CHARLES | 1637 | Final Rejection | Oct 01, 2021 |
| 17467574 | CD4 T cells provide antibody access to immunoprivileged tissue | SWARTWOUT, BRIANNA KENDALL | 1644 | Final Rejection | Sep 07, 2021 |
| 17314653 | SYSTEMS AND METHODS FOR BI-DIRECTIONAL ENDOVASCULAR ACCESS FOR DIAGNOSTIC AND THERAPEUTIC INTERVENTIONS | ZAMORY, JUSTIN L | 3783 | Non-Final OA | May 07, 2021 |
| 17289882 | Quantitative Algorithm for Endometriosis | LIU, GUOZHEN | 1686 | Non-Final OA | Apr 29, 2021 |
| 17226793 | METHODS FOR TREATING AORTIC ANEURYSM DISEASE | MARTIN, PAUL C | 1653 | Final Rejection | Apr 09, 2021 |
| 17272124 | COMPOSITIONS AND METHODS OF USING CELL-PENETRATING ANTIBODIES IN COMBINATION WITH IMMUNE CHECKPOINT MODULATORS | ESSEX, LAURA ANN | 1675 | Final Rejection | Feb 26, 2021 |
| 17160050 | TARGETING GENE AMPLIFICATION IN CANCER USING TRIPLEX FORMATION AS A THERAPEUTIC STRATEGY | HUDSON, AMY ROSE | 1636 | Final Rejection | Jan 27, 2021 |
| 17054115 | COMPOSITIONS AND SYSTEMS FOR EX VIVO CELL MODULATION AND METHODS OF USE THEREOF | TIWARI, VYOMA SHUBHAM | 1634 | Final Rejection | Nov 09, 2020 |
| 15548197 | INTEGRATED PAINLESS BONE MARROW BIOPSY DEVICE | CATINA, MICHAEL ANTHONY | 3791 | Final Rejection | Aug 02, 2017 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial